[
    [
        {
            "time": "",
            "original_text": "【天风医药】健帆生物：上半年业绩维持高增长，疫情助力境外市场扩张",
            "features": {
                "keywords": [
                    "健帆生物",
                    "上半年业绩",
                    "高增长",
                    "疫情",
                    "境外市场",
                    "扩张"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风医药】健帆生物：上半年业绩维持高增长，疫情助力境外市场扩张",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]